Roswell Park Comprehensive Cancer Center

Our News on Newswise
View All >

Newswise: 6658d9be7889c_GandhiShipraAugust062018.jpg

Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall...
30-May-2024 4:25 PM EDT Add to Favorites

Newswise: 6658d8a1dbabd_AryaMariamRoyMD.jpg

Study Shows Polygenic Risk Score (PGS) Could Predict Breast Cancer Survival Outcomes

Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer.
30-May-2024 4:00 PM EDT Add to Favorites

Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations

New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park Comprehensive Cancer Center experts will deliver at the American Society of Clinical Oncology...
24-May-2024 4:05 PM EDT Add to Favorites

Newswise: 661420322bc3c_YendamuriHeadshot2023.jpg

Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients

Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a...
8-Apr-2024 1:20 PM EDT Add to Favorites

Newswise: 65dcb85433e1f_fountzilasbakin.jpg

Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers

A preclinical study led by a team of researchers at Roswell Park Comprehensive Cancer Center highlights the potential of a novel two-drug treatment strategy targeting p53-mutant cancers.
26-Feb-2024 11:30 AM EST Add to Favorites

Novel Treatment Regimen for FLT3-Mutated Acute Myeloid Leukemia Shows Promise in Roswell Park-Led Study

Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis.
8-Feb-2024 3:00 PM EST Add to Favorites

Roswell Park Study Defines Mechanisms Underlying Promising Precision Therapy for Pancreatic Cancer

A research study led by a multidisciplinary team of scientists at Roswell Park Comprehensive Cancer Center details evidence on the therapeutic efficacy of a compound that targets a key genetic feature of pancreatic cancer.
2-Feb-2024 1:55 PM EST Add to Favorites

Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes

As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies.
2-Feb-2024 1:40 PM EST Add to Favorites

See All News

Our Experts on Newswise

Newswise: 63fcdf4a50e8d_DrThanavalaFebruary142020035.jpg

Vaping CBD can increase susceptibility to respiratory infection, says Roswell Park study author

27-Feb-2023 12:45 PM EST

Roswell Park: Racial Disparities From Cervical Cancer Are a Wake-Up Call

25-Jan-2017 10:05 AM EST

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

See All Experts

About

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or [email protected].